The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance
Open accessAbstract
Schistosomiasis, a major neglected tropical disease, affects more than 250 million people worldwide. Treatment of schistosomiasis has relied on the anthelmintic drug praziquantel (PZQ) for more than a generation. PZQ is the drug of choice for the treatment of schistosomiasis; it is effective against all major forms of schistosomiasis, although it is less active against juvenile than mature parasites. A pyrazino-isoquinoline derivative, PZQ is not considered to be toxic and generally causes few or transient, mild side effects. Increasingly, mass drug administration targeting populations in sub-Saharan Africa where schistosomiasis is endemic has led to the appearance of reduced efficacy of PZQ, which portends the selection of drug-resistant forms of these pathogens. The synthesis of improved derivatives of PZQ is attracting attention, e.g., in the (i) synthesis of drug analogues, (ii) rational design of pharmacophores, and (iii) discovery of new compounds from large-scale screening programs. This article reviews reports from the 1970s to the present on the metabolism and mechanism of action of PZQ and its derivatives against schistosomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colley, D. G., Bustinduy, A. L., Secor, W. E., & King, C. H. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61949-2 · Cited by 2,444
Gryseels, B., Polman, K., Clerinx, J., & Kestens, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69440-3 · Cited by 2,084
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Prevention and control of schistosomiasis and soil-transmitted helminthiasis.
(2002) · PubMed · Cited by 1,518
Hotez, P. J., Alvarado, M., Basáñez, M.-G., Bolliger, I., Bourne, R., Boussinesq, M., Brooker, S. J., Brown, A. S., Buckle, G., Budke, C. M., et al. (2014) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002865 · Cited by 1,082
Ross, A. G. P., Bartley, P. B., Sleigh, A. C., Olds, G. R., Li, Y., Williams, G. M., & McManus, D. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra012396 · Cited by 870
Lindenberg, M., Kopp, S., & Dressman, J. B. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.001 · Cited by 864
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
Doenhoff, M. J., Cioli, D., & Utzinger, J. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328318978f · Cited by 806
BDDCS Applied to Over 900 Drugs
Benet, L. Z., Broccatelli, F., & Oprea, T. I. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9290-9 · Cited by 626
van Wyk, J. A. (2001) · PubMed · Cited by 528
(2012) · PubMed Central · Cited by 502
Fallon, P. G., & Doenhoff, M. J. (1994) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1994.51.83 · Cited by 483
Plasma protein binding: From discovery to development
Bohnert, T., & Gan, L.-S. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23614 · Cited by 430
Schistosomiasis control: praziquantel forever?
Cioli, D., Pica-Mattoccia, L., Basso, A., & Guidi, A. (2014) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2014.06.002 · Cited by 395
Susceptibility or resistance of praziquantel in human schistosomiasis: a review
Wang, W., Wang, L., & Liang, Y.-S. (2012) · Parasitology Research · doi:10.1007/s00436-012-3151-z · Cited by 384
Andrews, P., Thomas, H., Pohlke, R., & Seubert, J. (1983) · Medicinal Research Reviews · doi:10.1002/med.2610030204 · Cited by 365
Pica‐Mattoccia, L., & Cioli, D. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2003.12.003 · Cited by 364
Cioli, D., & Pica-Mattoccia, L. (2003) · Parasitology Research · doi:10.1007/s00436-002-0751-z · Cited by 343
Ismail, M., Metwally, A., Farghaly, A., Bruce, J., Tao, L.-F., & Bennett, J. L. (1996) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1996.55.214 · Cited by 315
Efficacy and Side Effects of Praziquantel in an Epidemic Focus of Schistosoma mansoni
Stelma, F. F., Talla, I., Sow, S., Kongs, A., Niang, M., Polman, K., Deelder, A. M., & Gryseels, B. (1995) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1995.53.167 · Cited by 310
New diagnostic tools in schistosomiasis
Utzinger, J., Becker, S. L., van Lieshout, L., van Dam, G. J., & Knopp, S. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.03.014 · Cited by 281
Gryseels, B. (2012) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2012.03.004 · Cited by 280
Open science is a research accelerator
Woelfle, M., Olliaro, P., & Todd, M. H. (2011) · Nature Chemistry · doi:10.1038/nchem.1149 · Cited by 260
Antischistosomal drugs: Past, present … and future?
Cioli, D., Pica-Mattoccia, L., & Archer, S. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00026-7 · Cited by 259
Pharmacokinetic variability of anticancer agents
Undevia, S. D., Gomez-Abuin, G., & Ratain, M. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1629 · Cited by 258
Resistance of Schistosoma mansoni to praziquantel: is there a problem?
Doenhoff, M. J., Kusel, J. R., Coles, G. C., & Cioli, D. (2002) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(02)90405-0 · Cited by 252
Savioli, L., Daumerie, D., Crompton, D. W. T., & Chan, M. (2013) · World Health Organization eBooks · Cited by 242
Pax, R., Bennett, J. L., & Fetterer, R. (1978) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00507974 · Cited by 234
Li, X.-Q., Bj�rkman, A., Andersson, T. B., Gustafsson, L. L., & Masimirembwa, C. M. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0636-9 · Cited by 232
Questionnaires for rapid screening of schistosomiasis in sub-Saharan Africa.
Lengeler, C., Utzinger, J., & Tanner, M. (2002) · Europe PMC (PubMed Central) · Cited by 167
Taste, A New Incentive to Switch to (R)-Praziquantel in Schistosomiasis Treatment
Meyer, T., Sekljic, H., Fuchs, S., Bothe, H., Schollmeyer, D., & Miculka, C. (2009) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000357 · Cited by 165
Olliaro, P., Delgado-Romero, P., & Keiser, J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt491 · Cited by 159
Towards an understanding of the mechanism of action of praziquantel
Aragon, A. D., Imani-Shikhabadi, R., Blackburn, V. R., Cupit, P. M., Melman, S. D., Goronga, T., Webb, T., Loker, E. S., & Cunningham, C. (2008) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2008.11.007 · Cited by 156
Murray, M. T. (2005) · Current Drug Metabolism · doi:10.2174/138920006774832569 · Cited by 145
Wilkinson, G. R. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00040-9 · Cited by 145
Water-based interventions for schistosomiasis control
Secor, W. E. (2014) · Pathogens and Global Health · doi:10.1179/2047773214y.0000000149 · Cited by 143
ALONSO, D., Muñóz, J., Gascón, J., Valls, M. E., & Corachan, M. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.74.342 · Cited by 140
Biot, C., Castro, W., Botté, C. Y., & Navarro, M. (2012) · Dalton Transactions · doi:10.1039/c2dt12247b · Cited by 136
Harnett, W., & Kusel, J. R. (1986) · Parasitology · doi:10.1017/s0031182000051568 · Cited by 130
Why Does Infection With Some Helminths Cause Cancer?
Brindley, P. J., da Costa, J. M. C., & Sripa, B. (2015) · Trends in cancer · doi:10.1016/j.trecan.2015.08.011 · Cited by 128
Self-citationCurrent status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt
Botros, S. S., Sayed, H. A. E., Amer, N. M., El-Ghannam, M., Bennett, J. L., & Day, T. A. (2005) · International Journal for Parasitology · doi:10.1016/j.ijpara.2005.02.005 · Cited by 128
Couto, F. F. B., Coelho, P. M. Z., Araújo, N., Kusel, J. R., Katz, N., Jannotti-Passos, L. K., & de Mattos, A. C. A. (2011) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762011000200006 · Cited by 128
Schistosome Calcium Channel β Subunits
Kohn, A. B., Anderson, P. A. V., ROBERTS-MISTERLY, J. M., & Greenberg, R. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100273200 · Cited by 125
New approaches for understanding mechanisms of drug resistance in schistosomes
Greenberg, R. M. (2013) · Parasitology · doi:10.1017/s0031182013000231 · Cited by 122
Activity of Praziquantel Enantiomers and Main Metabolites against Schistosoma mansoni
Meister, I., Ingram-Sieber, K., Cowan, N., Todd, M. H., Robertson, M. N., Meli, C., Patra, M., Gasser, G., & Keiser, J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02741-14 · Cited by 105
Nogi, T., Zhang, D., Chan, J. D., & Marchant, J. S. (2009) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000464 · Cited by 105
ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics
Lespine, A., Alvinerie, M., Vercruysse, J., Prichard, R. K., & Geldhof, P. (2008) · Trends in Parasitology · doi:10.1016/j.pt.2008.03.011 · Cited by 104
Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis
Mandour, M. E. M., Elturabi, H., Homeida, M. M. A., Sadig, T., Ali, H. M., Bennett, J. L., Leahey, W. J., & Harron, D. W. G. (1990) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(90)90333-a · Cited by 95
Woelfle, M., Seerden, J.-P. G., de Gooijer, J. M., Pouwer, K., Olliaro, P., & Todd, M. H. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001260 · Cited by 93
Schistosomiasis and Its Treatment
Caffrey, C. R. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.27 · Cited by 91
What is the Mechanism of Action of Praziquantel and How Might Resistance Strike?
Cupit, P. M., & Cunningham, C. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.11 · Cited by 81
Drug Information Handbook: A Comprehensive Resource for All Clinicians and Healthcare Professionals
Lacy, C. F. (2004) · Medical Entomology and Zoology · Cited by 80
Berhe, N. B., Gundersen, S. G., Abebe, F., et al. (1999) · Acta Tropica · doi:10.1016/s0001-706x(98)00084-9 · Cited by 75
Schistosomiasis‐Associated Pulmonary Hypertension
Papamatheakis, D. G., Mocumbi, A. O., Kim, N. H., & Mandel, J. (2014) · Pulmonary Circulation · doi:10.1086/678507 · Cited by 73
Pica‐Mattoccia, L., Orsini, T., Basso, A., Festucci, A., Liberti, P., Guidi, A., Marcatto-Maggi, A.-L., Nobre-Santana, S., Troiani, A. R., Cioli, D., et al. (2008) · Experimental Parasitology · doi:10.1016/j.exppara.2008.03.012 · Cited by 70
Kasinathan, R. S., Morgan, W. M., & Greenberg, R. M. (2010) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2010.05.003 · Cited by 69
Lier, T., Simonsen, G. S., Wang, T., Lu, D., Haukland, H. H., Vennervald, B. J., Hegstad, J., & Johansen, M. V. (2009) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.81.428 · Cited by 67
Laboratory induced resistance to praziquantel in experimental schistosomiasis.
Ismail, M. M., Taha, S., Farghaly, A., & el-Azony, A. S. (1994) · PubMed · Cited by 66
You, H., McManus, D. P., Hu, W., Smout, M. J., Brindley, P. J., & Gobert, G. N. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003254 · Cited by 65
Self-citationResults of toxicological studies on praziquantel.
Frohberg, H. (1984) · PubMed · Cited by 64
Kohn, A. B., ROBERTS-MISTERLY, J. M., Anderson, P. A. V., Khan, N. Y. A. J. A., & Greenberg, R. M. (2003) · Parasitology · doi:10.1017/s003118200300386x · Cited by 60
Human Schistosomiasis Resistance to Praziquantel in China: Should We Be Worried?
Seto, E. Y. W., Wong, B. K., Lu, D., & Zhong, B. (2011) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2011.10-0542 · Cited by 60
Metabolism of praziquantel in man
Bühring, K. U., Diekmann, H. W., Müller, H., Garbe, A., & Nowak, H. (1978) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03189504 · Cited by 57
Transcriptional analysis of Schistosoma mansoni treated with praziquantel in vitro
Hines-Kay, J., Cupit, P. M., Sanchez, M. C., Rosenberg, G. H., Hanelt, B., & Cunningham, C. (2012) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2012.09.006 · Cited by 57
Rinaldi, G., Loukas, A. C., Brindley, P. J., Irelan, J., & Smout, M. J. (2015) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2015.07.002 · Cited by 54
Self-citationCytochalasin D abolishes the schistosomicidal activity of praziquantel
Pica‐Mattoccia, L., Valle, C., Basso, A., Troiani, A. R., Vigorosi, F., Liberti, P., Festucci, A., & Cioli, D. (2006) · Experimental Parasitology · doi:10.1016/j.exppara.2006.09.017 · Cited by 53
Huang, J., Bathena, S. P., & Alnouti, Y. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rg-041 · Cited by 53
Lima, R. M., Ferreira, M. A. D., Carvalho, T. M. D. J. P., et al. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03874.x · Cited by 47
Two Schistosoma mansoni cDNAs encoding ATP-binding cassette (ABC) family proteins
Bosch, I., Wang, Z.-X., Tao, L.-F., & Shoemaker, C. B. (1994) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(94)90085-x · Cited by 47
Characterisation of praziquantel metabolism by rat liver microsomes using cytochrome P450 inhibitors
Masimirembwa, C. M., & Hasler, J. A. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90464-2 · Cited by 44
‘Death and Axes’: Unexpected Ca2+ Entry Phenologs Predict New Anti-schistosomal Agents
Chan, J. D., Agbedanu, P. N., Zamanian, M., Gruba, S. M., Haynes, C. L., Day, T. A., & Marchant, J. S. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003942 · Cited by 42
Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel
Kasinathan, R. S., Goronga, T., Messerli, S. M., Webb, T. R., & Greenberg, R. M. (2009) · The FASEB Journal · doi:10.1096/fj.09-137091 · Cited by 37
Kramers, P. G. N., Gentile, J. M., Gryseels, B., Jordan, P., Katz, N., Mott, K. E., Mulvihill, J. J., Seed, J. L., & Frohberg, H. (1991) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(91)90019-r · Cited by 34
抗住血吸虫症薬の遺伝毒性と発癌性の総説 突然変異疫学研究の一例となるか 変異原性抗住血吸虫症薬に関する作業部会報告
Kramers, P. G. N., Gentile, J. M., M, G. B. J. A., Jordan, P., Katz, N., Mott, K. E., Mulvihill, J. J., Seed, J. L., & Frohberg, H. (1991) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · Cited by 25
Ali, B. H. (2006) · PubMed · Cited by 24
Ferreira, M. S., de Oliveira, R. N., de Oliveira, D. N., et al. (2015) · International Journal for Parasitology · doi:10.1016/j.ijpara.2014.12.008 · Cited by 23
Chemotherapy and Drug Resistance in Schistosomiasis,Fascioliasis and Tapeworm Infections
Doenhoff, M. J., Coles, G. C., Pica‐Mattoccia, L., & Wheatcroft-Francklow, K. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_45 · Cited by 6
Cited by
Gastrointestinal synthetic epithelial linings
Li, J., Wang, T., Kirtane, A. R., Shi, Y., Jones, A., Moussa, Z., Lopes, A., Collins, J., Tamang, S. M., Hess, K., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc0441 · Cited by 70
Munyangi, J., Cornet-Vernet, L., Idumbo, M., Lu, C., Lutgen, P., Perronne, C., Ngombe, N., Bianga, J., Mupenda, B., Lalukala, P., et al. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.10.014 · Cited by 40
Retracted
Metadata
- Authors
- Vale, N., Gouveia, M. J., Rinaldi, G., Brindley, P. J., Gärtner, F., & Correia da Costa, J. M.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2017-05
- Volume
- 61
- Issue
- 5
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2594312336
- Cited by
- 388
- References
- 77
- FWCI
- 24.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.